Ovid Therapeutics (OVID) Total Debt (2019 - 2020)
Ovid Therapeutics (OVID) posted Total Debt of $2.4 million for Q4 2020, up 745.29% on a QoQ basis from $287736.0 in Q3 2020, and up 717.91% year-over-year from $297366.0 in Q1 2020.
Ovid Therapeutics (OVID) Total Debt (2019 - 2020) Analysis & Trends
Ovid Therapeutics' Total Debt history runs 2 years deep, the most recent figure standing at $2.4 million for Q4 2020.
- Quarterly Total Debt rose 717.91% year-over-year to $2.4 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $2.4 million (up 717.91% YoY) and the FY2020 annual result came in at $2.4 million, up 717.91% from the prior year.
- Total Debt was $2.4 million for Q4 2020 at Ovid Therapeutics, up from $287736.0 in the prior quarter.
- Across five years, Total Debt topped out at $2.4 million in Q4 2020 and bottomed at $287736.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 959.06 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.43 Mn |
| Sep 30, 2020 | 287,736.00 |
| Jun 30, 2020 | 297,366.00 |
| Mar 31, 2020 | 297,366.00 |
| Dec 31, 2019 | 297,366.00 |
| Sep 30, 2019 | 624,335.00 |
| Jun 30, 2019 | 1.35 Mn |
| Mar 31, 2019 | 1.34 Mn |